These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36059494)

  • 21. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs.
    Xu C; Chen Z; Pan X; Liu M; Cheng G; Li J; Mei Y
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6255-6269. PubMed ID: 35904674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
    Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
    Front Genet; 2022; 13():833928. PubMed ID: 35330731
    [No Abstract]   [Full Text] [Related]  

  • 24. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
    Tu H; Zhang Q; Xue L; Bao J
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
    Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
    Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.
    Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z
    Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
    Fan Z; Wang Y; Niu R
    Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma.
    Huang Y; Yang Z; Huang C; Jiang X; Yan Y; Zhuang K; Wen Y; Liu F; Li P
    Front Oncol; 2021; 11():725181. PubMed ID: 34646770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.
    Zhu X; Xie X; Zhao Q; Zhang L; Li C; Zhao D
    Biomed Res Int; 2020; 2020():4673153. PubMed ID: 32685487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
    Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
    Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma.
    Xu Z; Xiang L; Peng L; Gu H; Wang Y
    Comput Math Methods Med; 2022; 2022():3445230. PubMed ID: 36148016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
    Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
    Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 36. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
    Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
    Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
    Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
    World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.
    Zhang L; Zhang Q; Huang Z; Zhu M; Wang T; Zhu W; Wang X; Zhou X
    Biomed Res Int; 2022; 2022():2053719. PubMed ID: 36193316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
    He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
    Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
    Zha Z; Zhang P; Li D; Liu G; Lu L
    Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.